Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Chronic Lymphocytic Leukemia Clinical Trials and Research

  • New Patient Appointments

    Make Appointment Online
    Dana-Farber Brigham Cancer Center logo
    US News adult badge - smaller
  • Clinical Trials Questions?



  • Matthew Davids, MD, MMSc, on Advances in CLL Treatment
    Matthew Davids, MD, MMSc, of Dana-Farber’s Center for Chronic Lymphocytic Leukemia, shares updates on advances in treating newly-diagnosed and relapsed CLL. New approaches include ibrutinib + FCR for younger, newly-diagnosed patients and a combination of rituximab and venetoclax for relapsed patients.

  • View Video Updates on Lymphoma and CLL Trial Research

    See and hear Dana-Farber faculty in informative videos, as they share updates and next steps for their lymphoma and CLL clinical trial research.